Vanguard Group Inc Tango Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,026,800 shares of TNGX stock, worth $27.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,026,800
Previous 3,875,545 3.9%
Holding current value
$27.5 Million
Previous $5.31 Million 288.34%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$1.1 - $5.47 $166,380 - $827,364
151,255 Added 3.9%
4,026,800 $20.6 Million
Q1 2025

May 09, 2025
SELL
$1.37 - $3.47 $150,261 - $380,589
-109,680 Reduced 2.75%
3,875,545 $5.31 Million
Q4 2024

Feb 11, 2025
BUY
$2.79 - $7.46 $948,382 - $2.54 Million
339,922 Added 9.32%
3,985,225 $12.3 Million
Q3 2024

Nov 13, 2024
BUY
$7.36 - $11.93 $2.58 Million - $4.18 Million
350,731 Added 10.65%
3,645,303 $28.1 Million
Q2 2024

Aug 13, 2024
BUY
$6.66 - $10.15 $1.42 Million - $2.17 Million
213,687 Added 6.94%
3,294,572 $28.3 Million
Q1 2024

May 10, 2024
BUY
$7.51 - $12.88 $763,564 - $1.31 Million
101,673 Added 3.41%
3,080,885 $24.5 Million
Q4 2023

Feb 14, 2024
BUY
$6.52 - $12.01 $256,685 - $472,821
39,369 Added 1.34%
2,979,212 $29.5 Million
Q3 2023

Nov 14, 2023
BUY
$2.93 - $11.26 $579,038 - $2.23 Million
197,624 Added 7.21%
2,939,843 $33.1 Million
Q2 2023

Aug 14, 2023
SELL
$2.67 - $4.7 $20,567 - $36,204
-7,703 Reduced 0.28%
2,742,219 $9.1 Million
Q1 2023

May 15, 2023
BUY
$3.76 - $8.06 $132,013 - $282,986
35,110 Added 1.29%
2,749,922 $10.9 Million
Q4 2022

Feb 10, 2023
BUY
$3.41 - $8.29 $378,741 - $920,753
111,068 Added 4.27%
2,714,812 $19.7 Million
Q3 2022

Nov 14, 2022
SELL
$3.25 - $5.46 $1.33 Million - $2.23 Million
-408,174 Reduced 13.55%
2,603,744 $9.43 Million
Q2 2022

Aug 12, 2022
BUY
$3.86 - $8.01 $1.15 Million - $2.39 Million
297,955 Added 10.98%
3,011,918 $13.6 Million
Q1 2022

May 13, 2022
BUY
$7.01 - $10.94 $8.88 Million - $13.9 Million
1,267,198 Added 87.59%
2,713,963 $20.6 Million
Q4 2021

Feb 14, 2022
BUY
$9.55 - $14.29 $591,517 - $885,108
61,939 Added 4.47%
1,446,765 $15.8 Million
Q3 2021

Nov 12, 2021
BUY
$9.56 - $17.3 $13.2 Million - $24 Million
1,384,826 New
1,384,826 $17.9 Million

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
117M
Call Options Held
245K
Put Options Held
18.9K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $601M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email